29 Amendments of Françoise GROSSETÊTE related to 2011/2193(INI)
Amendment 4 #
Motion for a resolution
Citation 9 a (new)
Citation 9 a (new)
- having regard to the Oviedo Convention on Human Rights and Biomedicine, and the additional protocol thereto on transplantation of organs and tissues of human origin,
Amendment 7 #
Motion for a resolution
Recital H
Recital H
H. whereas public awareness and opinthe dissemination of clear, fair, scientifically based and conclusive medical information play a very important role in gaining public support and increasing tissues and cells donation rates;
Amendment 12 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. whereas the removal of tissues and cells for the benefit of recipients may only be carried out under two conditions: it must be done with a medical or scientific and therapeutic aim, and all the elements removed must be donated without any payment being made;
Amendment 13 #
Motion for a resolution
Recital K b (new)
Recital K b (new)
Kb. whereas the removal of tissue and cells must be subject to the following principles: anonymity (except in the case of removal from a living person for a relative), non-remuneration, consent, the obligation to share organs for transplant fairly among patients, and health safety for donors and recipients;
Amendment 14 #
Motion for a resolution
Recital L
Recital L
L. whereas a healthcare intervention may only be carried out after the person concernedtissues and cells may only be removed if the donor has given prior free and informed consent to iin writing to it; whereas this consent may be withdrawn at any time, and with no particular requirement as to format;
Amendment 15 #
Motion for a resolution
Recital M
Recital M
M. whereas the use of tissues and cells for application in the human body carries a risk of disease transmission and other potential adverse effects inof disease to recipients. That risk can be reduced by careful donor selection, testan evaluation of potential donors prior to procurement based on a risk/benefit analysis, testing and monitoring of each donation and the application of procedures to procure tissues and cells in accordance with rules and processes established and updated according to the best available scientific advice;
Amendment 26 #
Motion for a resolution
Subheading 1
Subheading 1
Amendment 28 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that donation should be voluntary and unpaid, and take place in clearly defined legal and ethical contextsmay only be carried out for medical or scientific and therapeutic purposes; that it is voluntary, anonymous (except in the case of procurement from a living person for a relative) and unpaid, and must be governed by protective legal and ethical rules which respect the integrity of the human person and are clearly defined;
Amendment 30 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Endorses measures aimed at protectingCalls on Member States to adopt protective measures for living donors and ensuringto guarantee that donation is made altruistically and voluntarily and considers the principle of altruism to be of fundamental importance, not merely because of the beneficial effect on the quality and safety of the donated cells and tissues, but also because it implies solidarity with the plight of othersanonymous (except in the case of procurement from a living person for a relative), voluntary, freely agreed to, informed and not remunerated;
Amendment 32 #
Motion for a resolution
Paragraph 3 b (new)
Paragraph 3 b (new)
3b. Points out that no payment, irrespective of the form it takes, may be given to a person who agrees to the removal of parts of his body or the collection of its products, and that the costs relating to such removal or collection are the sole responsibility of the health establishment responsible for conducting the removal or collection;
Amendment 36 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls on Member States to define the conditions under which financialair and proportionate compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the expenses incurred in donating an organ, such as travel expenses, loss of earnings or medical costs, and thereby prohibiting any financial incentives or disadvantages for a potential donor;
Amendment 42 #
Motion for a resolution
Paragraph 5
Paragraph 5
Amendment 44 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Calls on Member States to ensure that living donors are selected on the basis of an evaluation of their health and medical history, including a psychological evaluation if deemed necessary, based on a risk-benefit analysis, by qualified orand trained and competent professionals;
Amendment 45 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Calls on Member States to take measures to protect minors and adults under guardianship with regard to the removal of tissues and cells;
Amendment 46 #
Motion for a resolution
Subheading 2
Subheading 2
Amendment 47 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Stresses that the principles of transparency isand safety are key to achieving a high level of public support for donation; encourages Member States to work towards creating a transparent donation system which upholds patient safety and increases traceability, which is particularly important when considering the donation of gameteis safe for donors and recipients;
Amendment 49 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Calls, in this light, on Member States to step up their public information and awareness-raising campaigns to promote the donation of tissues and cells and to ensure the provision of adequatemedical information and data in order tothat is clear, fair, scientifically based and conclusive and data enableing the public to make informed choices;
Amendment 54 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Highlights the legal and ethical problems posed by the existence of websites permitting people to sell or purchase gametes online; calls on Member States to consider regulating this area to prevent the possible emergence of such an online black market;
Amendment 56 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls on Member States to make a concerted effort to participate in thestep up exchanges of bestgood practices in, particularly with regards to dealing with shortages in the supply of tissues and cells and on how to bestthe supply of tissues and cells, the protection of the quality of tissues and cells while they are being transported, raiseing awareness of donating tissues and cellsand training health staff;
Amendment 59 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Recognises the significant scientific advances made in the cord blood field and the potential uses of cord blood to treat, which is a very promising therapeutic alternative in the treatment of many diseases, including children’s illnesses;
Amendment 60 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14a. Stresses that clinical trials using cord blood stem cells for treatments linked to non-haematopoietic illnesses have taken place outside the European Union (in the United States of America and in countries in Asia); calls, therefore, on the European Commission and Member States to take the necessary measures to ensure that the European Union does not fall behind in this field, and in particular to create a regulatory framework that will increase the availability of cord blood stem cells for allogeneic and autologous uses;
Amendment 67 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Underlines the importance of mothers donating cord blood and tissue at birth either into public or private non-profit- making banks to help treat illnesses and further research in the field;
Amendment 70 #
Motion for a resolution
Paragraph 15 c (new)
Paragraph 15 c (new)
15c. Points out that this donation must be subject to consent from the mother that is free, informed and given in writing, and that this consent may be withdrawn at any time prior to the donation, with no particular requirement as to format;
Amendment 74 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on Member States to raise awareness of public and privatethe existence and value of public and private non-profit-making cord blood banking through information campaigns that may take place, for example, during antenatal classes;
Amendment 77 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16a. Proposes that, in compliance with the provisions of the Charter of Fundamental Rights of the European Union, the information campaigns should ensure that parents have an informed choice about the various options relating to the use of the baby’s cord blood;
Amendment 83 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. Proposes that Member States consider adopting and enforcing common operational and ethical standards for both public and private non-profit-making cord blood banks, such as those proposed by non-profit organisations such as the International Netcord Foundation and the Foundation for the Accreditation of Cellular Therapy (FACT);
Amendment 86 #
Motion for a resolution
Paragraph 17 c (new)
Paragraph 17 c (new)
17c. Calls on Member States to provide a territorial network of maternity centres authorised to carry out this procurement to guarantee cord blood supply in all population centres;
Amendment 89 #
Motion for a resolution
Paragraph 17 f (new)
Paragraph 17 f (new)
17f. Highlights the legal and ethical questions raised by the autologous use of cord blood cells, namely the storage by banks of cord blood cells from newborn babies in exchange for payment, with a view to later therapeutic use on the child in the event of an illness; calls, therefore, for a ban on all autologous donation;
Amendment 91 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Encourages public and privMember States’ cord blood banks to collaborate more closely in order to increase the availability of and exchange of national, European and international cord blood and tissue samples;